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ttp://dx.doi.org/10.1016/j.ajpath.2015.02.008Hepatic progenitor/oval cell (OC) activation occurs when hepatocyte proliferation is inhibited and is
tightly associated with the ﬁbrogenic response during severe liver damage. Connective tissue growth
factor (CTGF) is important for OC activation and contributes to the pathogenesis of liver ﬁbrosis. By
using the Yeast Two-Hybrid approach, we identiﬁed a disintegrin and metalloproteinase with throm-
bospondin repeat 7 (ADAMTS7) as a CTGF binding protein. In vitro characterization demonstrated CTGF
binding and processing by ADAMTS7. Moreover, Adamts7 mRNA was induced during OC activation, after
the implantation of 2-acetylaminoﬂuorene with partial hepatectomy in rats or on feeding a 3,5-
diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet in mice. X-Gal staining showed Adamts7 expression in
hepatocyte nuclear factor 4aþ hepatocytes and desminþ myoﬁbroblasts surrounding reactive ducts in
DDC-treated Adamts7/ mice carrying a knocked-in LacZ gene. Adamts7 deﬁciency was associated
with higher transcriptional levels of Ctgf and OC markers and enhanced OC proliferation compared to
Adamts7þ/þ controls during DDC-induced liver injury. We also observed increased a-smooth muscle actin
and procollagen type I mRNAs, large ﬁbrotic areas in a-smooth muscle actin and Sirius red staining, and
increased production of hepatic collagen by hydroxyproline measurement. These results suggest that
ADAMTS7 is a new protease for CTGF protein and a novel regulator in the OC compartment, where its
absence causes CTGF accumulation, leading to increased OC activation and biliary ﬁbrosis. (Am J Pathol
2015, 185: 1552e1563; http://dx.doi.org/10.1016/j.ajpath.2015.02.008)Supported by NIH RO1 grants DK058614 and DK065096 (B.E.P.) and
EY05587 (G.S.S.) and partly supported by NIH RO1 grant EY05587-26
(G.S.S.) and American Cancer Society Chris DiMarco Institutional
Research grant (L.P.).
Disclosures: None declared.The liver possesses a remarkable capacity to regenerate in
response to injury. Hepatocytes can quickly re-enter the cell
cycle and repair liver damage under normal conditions.When
the replicative ability of hepatocytes is obstructed during
severe liver damage or in chronic liver disease, a reserve cell
population termed hepatic progenitor cells (HPCs) in
humans, also referred to as oval cells (OCs) in rodents, is
activated and expanded extensively in the form of ductular
reaction around periportal areas during liver repair.1e3 HPCs/
OCs represent a heterogeneous population of proliferating
epithelial cells existing in various intermediate states between
biliary epithelial cells and hepatocytes.1e3 The origin ofstigative Pathology.
.HPCs/OCs is controversial and varies on the basis of extent,
type, and location of the injury. These cells have been
considered as progeny of facultative liver stem cells from the
smallest and most peripheral branches of the biliary tree and
contribute to the regenerative process of biliary trees and
liver parenchyma.1,2,4 However, recent reports using lineage
ADAMTS7 in Liver Repairtracing studies inmice have demonstrated little contribution of
HPCs/OCs in liver regeneration, with repopulated liver cells
mainly derived from dedifferentiated hepatocytes or biliary
epithelial cells.5e8 Ectopic activation of Yes-associated pro-
tein in differentiated hepatocytes can result in their dediffer-
entiation, driving liver overgrowth andHPC/OC appearance.9
Deletion of the recombining binding protein suppressor
of hairless (RBP-J) effector of Notch signaling abolishes
this Yes-associated proteinemediated transdifferentiation
between hepatocytes and HPCs/OCs.9 These phenomena
demonstrate a considerable degree of plasticity from multiple
cell types in the livers and an ambiguous function for HPCs/
OCs in liver regeneration.Nevertheless, HPC/OC activation is
closely associated with the ﬁbrotic response in many experi-
mental animal models and chronic liver diseases.10 Under-
standing the mechanisms underlying HPC/OC activation and
liver ﬁbrosis is imperative in the development of therapeutic
strategies targeting chronic liver diseases.
Several HPC/OC niches have been identiﬁed in the
liver. Label-retaining cell assays in murine acetaminophen-
induced liver injury have demonstrated that the Canals of
Hering, bile ductules within the portal tract, and the periportal
parenchyma are the niche locations.11 Different cell types,
including hepatocytes, cholangiocytes, myoﬁbroblasts, endo-
thelial cells, macrophages, and inﬂammatory cells, coexist in
the niches and inﬂuence the regenerative process by releasing a
variety of extracellular matrix (ECM) components, growth
factors, and cytokines.12e14 Matricellular proteins in the
cysteine-rich angiogenic inducer 61 (Cyr61)/connective tissue
growth factor (CTGF)/Nov protein family serve as important
signal modiﬁers in stem cell niches and can modulate Notch,
Wnt, and transforming growth factor-b pathways.15e18 CTGF,
or Cyr61/CTGF/Nov 2, is a downstream target of Yes-
associated protein and highly expressed in HPCs/OCs and
cholangiocytes during liver injury.9,19e21 Its overexpression is
noted as a hallmark of liver ﬁbrosis.22,23 CTGF protein can
exert activity onvarious types of cells through its broad binding
capabilities to ECM proteins, growth factors, and cell surface
proteins, such as proteoglycans and different integrin sub-
types.23 It has been considered as a potential therapeutic target
for ﬁbrotic disorders.24 Recently, we have shown that CTGF
can function together with the epithelial-speciﬁc integrin avb6
to promote the activation of transforming growth factor-b,
produce the adhesion of OCs to ﬁbronectin, which enriches the
provisional matrix, and potentiate biliary ﬁbrosis induced by
3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC).21 Inhibi-
tion of CTGF expression signiﬁcantly decreases OC activation
and liver ﬁbrosis in experimental animal studies.20,21,25e27
Herein, we used the Yeast Two-Hybrid approach and
identiﬁed a disintegrin and metalloproteinase with thrombo-
spondin motif 7 (ADAMTS7) as a CTGF binding protein.
ADAMTS7 belongs to the ADAMTS family of extracellular
proteases involved in organ structure and remodeling through
cleaving ECM components and affecting extracellular regu-
latory molecules.28e30 Adamts7 was induced in two
OC activation models: implantation of 2-acetylaminoﬂuoreneThe American Journal of Pathology - ajp.amjpathol.org(2-AAF) in combination with partial hepatectomy (PHx) in
rats and the feeding of a DDC diet in mice. By using Adamts7
knockout (KO) mice carrying a targeted Adamts7 allele and
the LacZ reporter cassette, we detected Adamts7 induction, as
indicated by b-galactosidase activity in hepatocytes and
myoﬁbroblast cells of the OC periportal niches. Adamts7
deﬁciency was found to up-regulate Ctgf, increase OC acti-
vation, and intensify biliary ﬁbrosis after DDC treatment.
These results indicate that ADAMTS7 modulates OC acti-
vation and the ﬁbrogenic response, most likely through con-
trolling CTGF turnover in the OC niche.
Materials and Methods
Yeast Two-Hybrid Analysis
The cDNA library screening and Yeast Two-Hybrid analyses
were described previously.31 Rat Ctgf or its truncated mutants
were fused with the DNA binding domain of GAL4 by cloning
into SalI/NotI sites of pPC97 vector.31 Adamts7 deletion mu-
tants were fused with the VP16 transactivation domain on
pPC86 vector, according to Liu et al.32 Plasmids corresponding
to these fusion proteins were cotransformed into yeast strain
CG1945 and grown under permissive conditions in SD media
lacking leucine and tryptophan. The binding of fusion proteins
was further analyzed bymonitoring transcriptional activation of
theHis3 reporter, thereby allowing cotransformant cells to grow
on selective SD media containing 5 mmol/L 3-amino-1,2,4-
triazole but lacking leucine, tryptophan, and histidine. CG1945
yeast strain and all the SDmediawere fromClontech (Mountain
View,CA). In addition, colony lift assayswere performed to test
the binding of fusion proteins in cotransformant cells on the
basis of transcriptional activation of LacZ reporter that encoded
b-galactosidase and turned X-Gal substrate into blue products
in Z buffer (60 mmol/L Na2HPO4, 40 mmol/L NaH2PO4,
10 mmol/L KCl, and 1 mmol/L MgSO4) containing 0.27%
b-mercaptoethanol and 0.3 mg/mL X-Gal.
Puriﬁcation of ADAMTS7 Catalytic Domain and the
in Vitro Cleavage Assay
The catalytic domain of ADAMTS7 (ADAMTS7CAT) was
ampliﬁed from a human cDNA plasmid reported previ-
ously33 and fused in-frame with C-terminal FLAG epitope at
HindIII and EcoRI sites of pFLAG-CTC vector (Sigma, St.
Louis, MO). The ADAMTS7CAT:FLAG fusion protein was
expressed in Escherichia coli DE3 strain, induced with 5
mmol/L isopropyl b-D-1-thiogalactopyranoside and puriﬁed
through M2 afﬁnity gels, according to the manufacturer’s
instructions. For the in vitro cleavage assay, recombinant
CTGF protein (Biovendor, Asheville, NC) was incubated
with the puriﬁed ADAMTS7CAT:FLAG protein (0.1 mg/mL)
in digestion buffer (50mmol/L Tris-HCL, 150mmol/L NaCl,
5 mmol/L CaCl2, 2 mmol/L ZnCl2, and 0.05% Brij-35, pH
7.5) from 0 to 16 hours at 37C. Digestion products were
resolved by 4% to 12% protein gel (Novex, Carlsbad, CA)1553
Pi et alunder reducing conditions and detected by Western blot
analysis using a rabbit polyclonal antibody speciﬁc for the
C-terminal region of CTGF (Abcam, Cambridge, MA).
Animal Experimentation
All animal protocols were approved by the University of
Florida (Gainesville) Animal Care and Usage Committee and
were conducted in compliance with their guidelines. The 2-
AAF/PHx protocol to induce liver regeneration in rats and
Northern analysis were described previously.20 For genera-
tion of Adamts7KOmice, in vitro fertilization was performed
with oocytes from 3-week-old C57BL6 females and sperm
carrying the Adamts7tm1a(KOMP)Wtsi allele (termed Adamts7
allele) from theKOMPRepository at University of California,
Davis. Germline transmission of the targeted Adamts7 allele
in the second generation was analyzed by Southern blotting
using a hybridization probe containing exon 6 that was PCR
ampliﬁed using primers 50-GGATCCAATTCTTGAAGT-
TCTGA-30 and 50-TGCTACCTAAACTGTAGGCACT-30
before [32P]-dCTP labeling (Amersham Life Science, Piscat-
away, NJ). The chimeras were intercrossed to generate
Adamts7/ mice, which were further interbred across more
than six generations. Transgenic mice carrying CTGF
promoter-driven green ﬂuorescent protein (GFP;CTGFp-GFP)
were described previously.21 Adamts7/, CTGFp-GFPþ/
mice were generated by backcrossing with Adamts7/ strain
for more than six generations. For the OC induction, approxi-
mately 10-week-old mice were fed with a diet supplemented
with 0.1% DDC (Bio-Serv, Frenchtown, NJ).21 Livers were
harvested and hepatic hydroxyproline content was measured
according to a previous publication.21
X-Gal Staining, Histological Analysis, and
Morphometric Measurement
For X-Gal staining, tissues were ﬁxed for 2 hours in ice-old
ﬁxative containing 1% formaldehyde, 0.2% glutaraldehyde,
and 0.02% Nonidet P-40 in phosphate-buffered saline, stained
by incubation at 37C for 16 hours with 1 mg/mL X-Gal, and
embedded in parafﬁn. X-Galestained liver sections (6 mm
thick)were further analyzedwith immunohistochemistry (IHC)
using primary antibodies, including rabbit anti-CTGF (Abcam)
at 1:200 dilution, Hepatocyte nuclear factor (HNF)4a (Santa
Cruz Biotechnology, Dallas, TX) at 1:200 dilution, desmin
(Abcam) at 1:200 dilution, rat anti-A6 (a kind gift from Dr.
Valentine Factor, National Cancer Institute, Bethesda, MD) at
1:50 dilution, CD45 (BD Biosciences, San Jose, CA) at 1:100
dilution, F4/80 (AbD Serotec, Raleigh, NC) at 1:300 dilution,
ﬁbronectin (Abcam) at 1:200 dilution, and laminin (Abcam) at
1:300 dilution. A rabbit b-galactosidase antibody (AVES Labs,
Tigard, OR) at 1:500 dilution was also used to determine the
expression pattern of Adamts7 gene in liver sections. The
immunoﬂuorescence staining for GFP, epithelial cell adhesion
molecule (EpCAM), andKi-67 was described previously.21 For
morphometric measurement, Ctgf expression was analyzed1554quantitatively on the basis of GFPþ areas in images (200
magniﬁcation) of liver sections fromDDC-treatedCTGFp-GFP
transgenic animals using ImageJ software version 1.46r (NIH,
Bethesda, MD). OC proliferation was calculated as a ratio
between the number of A6þ Ki-67þ cells/total number of A6þ
cells from images (200 magniﬁcation). For the evaluation of
ﬁbrogenesis, liver sections were stained with Picrosirius red
solution (American MasterTech Scientiﬁc, Lodi, CA) or with a
mouse a-smooth muscle actin (a-SMA) antibody (Sigma), fol-
lowed by ABC kit detection (Vector Laboratories, Burlingame,
CA). Borders of positively stained areas in each periportal ﬁeld
were traced at 200 objective magniﬁcation, and the corre-
sponding areas were measured in pixels using ImageJ software.
Total positive areas were calculated as a percentage of total
pixels in each image. At least ﬁve random-ﬁeld images were
taken per slide, and three animals per group were scored.
RT-PCR Data
Total liver RNA extraction and semiquantitative RT-PCR
analysis using primers for Ctgf, EPCAM, CK19 (KRT19),
a-SMA (ACTA2), procollagen I(a) (COL1A1), Trop2
(TACSTD2), and 18S genes were described previously.21,34
Exons 4 to 7 of theAdamts7 genewere ampliﬁed using primers
50-TGTGCGCCTTATCATACTGGAAGA-30 (sense) and
50-CACATGGCTGGTTCATGGACGCA-30 (antisense).
Western Blot Analysis and Immunoprecipitation Assays
Chinese hamster ovary cells expressing 3xFLAG-tagged
CTGF (CTGF:3xFLAG) or CTGF-I that contained the ﬁrst
domain I (CTGF-I:3xFLAG) were described previously.31
ADAMTS7:V5 and ADAMTS7-C:V5 plasmids were
generated by PCR ampliﬁcation of rat ADAMTS7 (http://
www.ncbi.nlm.nih.gov/nuccore; Genbank accession number
AY257482.1) or ADAMTS7-C cDNAs, followed by cloning
into BamHI and NotI sites in front of V5 epitope sequence in
pEF6 vector (Invitrogen, Grand Island, NY). For Western
blot analysis, total proteins were extracted from mouse livers
or cultured cells using cold radioimmunoprecipitation assay
buffer containing complete proteinase inhibitor (Sigma).
Total protein lysates (50 mg) were boiled in 1 Laemmli
buffer containing 5% b-mercaptoethanol, separated on 4% to
12% Bis-Tris protein gels, and transferred onto a poly-
vinylidene diﬂuoride membrane for immunoblotting. Rabbit
antibodies for CTGF (dilution 1:2000) and b-actin (Abcam),
with dilution of 1:5000, were used in Western blot analysis.
Proteins were detected using horseradish peroxidasee
conjugated secondary antibodies (Santa Cruz Biotechnology)
and the ECL Plus kit (Amersham). For immunoprecipitation
assays, 1 mg/mL total protein lysates in cold radio-
immunoprecipitation assay buffer were precleared with
protein A/G beads (Santa Cruz Biotechnology) and immuno-
precipitated with M2-conjugated agarose beads (Sigma). Im-
mune complexes were washed in radioimmunoprecipitation
assay buffer, separated onto SDS-PAGE gels, and transferredajp.amjpathol.org - The American Journal of Pathology
ADAMTS7 in Liver Repaironto a polyvinylidene diﬂuoride membrane. Horseradish
peroxidaseeconjugated M2 antibody (Sigma) or V5 antibody
(Invitrogen) was used to detect tagged CTGF, ADAMTS7, or
their truncation mutants by immunoblotting.
Statistical Analysis
Microsoft Excel software version 14.2.4 (Microsoft Corp.,
Redmond, WA) was used for statistical analysis. A Student’s
t-test was used, and P < 0.05 was considered statistically
signiﬁcant. Three to four independent repeats were conducted
in all of the experiments. Data are presented as means  SEM.
Results
ADAMTS7 Interacts with CTGF in a Yeast Two-Hybrid
System and Tissue Culture Conditions
To understand the molecular mechanism of OC activation,
we used the ﬁrst three domains of CTGF as bait and screened
a Yeast Two-Hybrid cDNA library using regenerating livers
from 2-AAF/PHxetreated rats.31 One candidate clone iso-
lated contained a 1.3-kb cDNA fragment that spanned from
nucleotide 2984 to the stop codon of the Adamts7 gene and
encoded the C-terminal region of the ADAMTS7 protein
containing a mucin domain, thrombospondin type I repeats
(TSRs) 5 to 8, and a protease and lacunin (PLAC) domain
(designated as ADAMTS7-C) (Figure 1A). The mucin
domain attaches to glycosaminoglycan chondroitin sulfate
and renders ADAMTS7 a proteoglycan.30 To identify the
minimal ADAMTS7 sequence that retained CTGF binding
ability in Yeast Two-Hybrid analysis, we generated a series
of truncated mutants that were in-frame fused with the VP16
transactivation domain. CTGF and its deletion mutants were
fused with the DNA binding domain of GAL4. CTGF,
ADAMTS7, or their mutants were cotransformed into yeast
cells. In theory, any protein-protein interaction would bring
the VP16 transactivation domain and the DNA binding
domain of GAL4 to a proximal distance, leading to tran-
scriptional activation of reporter genes His3 and LacZ in
cotransformed yeast cells. As a result, those cotransform-
ants would grow on selective media and turn blue on colony
lift assays because of b-galactosidase activity. ADAMTS7-
C containing a mucin domain, TSRs 5 to 8, and the
PLAC domain was required for interaction with CTGF
(Figure 1A). Moreover, CTGF-I was sufﬁcient for binding
to ADAMTS7-C (Figure 1B). To investigate these in-
teractions in mammalian expression system, we fused rat
ADAMTS7-C or human ADAMTS7 cDNAs with V5 tag
and expressed them under the control of human ubiquitin C
promoter in Chinese hamster ovary cells (Figure 1C).
Immunoprecipitation assays showed that ADAMTS7:V5
and ADAMTS7-C:V5 speciﬁcally co-immunoprecipited
with CTGF:3xFLAG or CTGF-I:3xFLAG in M2 afﬁnity
gel in comparison to vector control (Figure 1D). Consistent
with previous ﬁndings that ADAMTS7 is retained near theThe American Journal of Pathology - ajp.amjpathol.orgsurface of cultured Chinese hamster ovary cells,32
ADAMTS7-C:V5 protein was pericellular and colo-
calized with many of CTGF-I:3xFLAG proteins in immu-
noﬂuorescence staining (Figure 1E). Taken together, these
results indicate that the C-terminal region of ADAMTS7
containing the mucin domain, the last three TSRs, and the
PLAG region interacts with domain I of CTGF protein.
ADAMTS7 Processes CTGF in Vitro
The catalytic domain of ADAMTS7, when expressed in bac-
teria, has been shown todigest its substrate, cartilage oligomeric
matrix protein, in vitro.32,33 We engaged a similar strategy and
expressed FLAG-tagged ADAMTS7 catalytic domain
(ADAMTS7CAT:FLAG) in E. coli. The ADAMTS7CAT:
FLAG fusion protein, approximately 28 kDa,was puriﬁed using
M2-conjugated beads, and its purity was veriﬁed by Coomassie
Blue staining (Figure 1F). Recombinant CTGF protein (5 ng/
mL) was incubated with the puriﬁed ADAMTS7CAT:FLAG
protein (0.1mg/mL) in digestion buffer containing divalentmetal
ions. From 0 to 16 hours after incubation, we observed the
accumulation of CTGF fragments with molecular weights esti-
mated at 70, 25, 20, and 12 kDa inWestern blot analysis using a
rabbit polyclonal antibody that recognized C-terminal CTGF
protein (Figure 1G), indicating binding and cleavage of CTGF
by ADAMTS7 in vitro.
Adamts7 Is Up-Regulated during OC Activation in
Regenerating Livers of 2-AAF/PHxeTreated Rats and in
Damaged Livers of DDC-Treated Mice
Our previous studies have shown induction of Ctgf gene
expression during OC activation in regenerating rat livers after
2-AAF/PHx and in injured mouse livers, caused by the DDC
diet.20,21 Thus, we examined Adamts7 expression in these two
OC activation models. Northern blot analysis using the
ADAMTS7-C fragment, identiﬁed in the Yeast Two-Hybrid
screening as probe, detected up-regulation of full-length
Adamts7 mRNA (approximately 5.5 kb) in regenerating livers
of rats that received the 2-AAF/PHx treatment at days 5, 7, 9,
11, and 13 in comparison to day 0 controls (Figure 2A). Feeding
mice with the DDC diet for up to 2 months also caused
increased expression of the Adamts7 gene. This was detected as
a PCR product with expected size (190 bp) using primers
speciﬁc for exons 4 and 7 in semiquantitative RT-PCR analysis
(Figure 2A). Consistent with our previous results from Ctgf
induction,20,21 the Adamts7 gene was up-regulated in similar
patterns during OC activation in rats after 2-AAF/PHx or in
mice after DDC treatment. These observations indicate that, like
Ctgf, the Adamts7 gene is involved in OC-mediated liver repair.
Adamts7 Is Expressed in OC Niches, Particularly in
Hepatocytes and Myoﬁbroblast Cells after DDC Treatment
To understand the in vivo function of Adamts7, we gener-
ated a KO mouse line using Adamts7 sperm in which the1555
Figure 1 ADAMTS7 interacts with and cleaves connective tissue growth factor (CTGF) in vitro.A andB: CTGF interaction with ADAMTS7 or truncated forms in Yeast
Two-Hybrid analyses. Schematic representation of ADAMTS7 and its truncation mutants. Plasmids carrying the ADAMTS7 mutants that were fused with the VP16
transactivation domain were cotransformed into yeast strain CG1945 with plasmids expressing CTGF or CTGF-I that was fused with GAL4 binding domain. Interaction
was evaluated on the basis of the growthof cotransformantson selectivemedia lacking tryptophan (Trp), leucine (Leu), andhistidine (His) in the presence of5mmol/L
3-amino-1,2,4-triazole. The interaction was also veriﬁed by color change of cotransformants in the colony lift assay because of b-galactosidase activity converting
X-Gal substrate into a blue product.C:ADAMTS7-C:V5and full-length ADAMTS7:V5 proteins were expressed in transfected Chinese hamster ovary (CHO) cells inWestern
blot analysis using V5-conjugated horseradish peroxidase (HRP) antibody. D: Immunoprecipitation (IP) assays detect speciﬁc associations of ADAMTS7-C:V5 and
ADAMTS7:V5 with CTGF:3xFLAG and CTGF-I:3XFLAG in immune complexes precipitated withM2 antibody from protein lysates of CHO cells that were cotransfected with
plasmids as indicated in the top panel. Equal input of CTGF protein in total lysates is veriﬁed in the bottom panel. E: Immunoﬂuorescence staining shows coloc-
alizationof CTGF:3xFLAGandADAMTS7-C:V5 proteins in cultured CHO cells. F: Coomassie Blue stainingdetects ADAMTS7CAT:FLAG protein puriﬁed from Escherichia coli
usingM2-afﬁnity gels.G:Western blot analysis detects accumulation of CTGF complex or small fragments after incubation with the puriﬁedADAMTS7CAT:FLAG protein
in vitro. Recombinant CTGF (5ng/mL)was incubatedwith0.1mg/mLADAMTS7CAT:FLAGprotein for 0 to16hours. A rabbit antibody that recognized C-terminal CTGFwas
used in the Western blot analysis. Scale barZ 5 mm. Cys, cysteine; IB, immunoblot; PLAC, protease and lacunin; TSR, thrombospondin type I repeat.
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ADAMTS7 in Liver RepairAdamts7þ allele was replaced by an Adamts7 target
construct (http://www.ncbi.nlm.nih.gov/genbank; Accession
number JN957348) in chromosome 9. This replaced region
includes upstream of exons 5 and 6 that correspond to the
catalytic core sequence of the Adamts7 gene in the mouse
genome (Figure 2B). There is a differential digestion pattern
by restriction enzyme EcoRI between Adamts7þ and
Adamts7 alleles. The Adamts7þ allele containing two EcoRI
sites was detected as a 23-kb fragment, whereas the Adamts7
allele produced a shorter 7-kb fragment after EcoRI digestion
because of the presence of a new EcoRI site in the targeted
construct (Figure 2C). The generation of Adamts7/ mice in
F2 populations was conﬁrmed by Southern blot analysis of
EcoRI-digested genomic DNA using a probe ﬂanking exon 6
of the Adamts7 gene. At the transcriptional level, the
Adamts7 target allele contained a mouse En2 intron 2/exon 3
splice acceptor sequence in front of an internal ribosomal
entry site and LacZ gene in a trapping cassette, which resulted
in a truncated Adamts7 mRNA containing only the ﬁrst four
exons and LacZ. The loss of the full-length Adamts7 transcript
in multiple tissues, including livers, was veriﬁed by RT-PCR
analysis using primers ﬂanking exons 4 and 7 from
Adamts7/ animals (Figure 2D). Moreover, we examined
Adamts7 expression indirectly using X-Gal staining to detect
the LacZ reporter. In the DDC model, b-galactosidase activity
was found in some A6þ bile ducts, althoughmost of A6þOCs
and cholangiocytes were not positive for the X-Gal staining
(Figure 2, E and F). HNF4aþ hepatocytes and desminþ
myoﬁbroblast cells within the OC niches that surrounded
reactive ducts had high levels of b-galactosidase activity,
indicating a strong induction of Adamts7 in these niche cells
(Figure 2, G and H). In contrast, CD45þ inﬂammatory cells
and F4/80þ macrophages lacked detectable Adamts7 expres-
sion, although these cells were closely associated with
Adamts7-expressing cells in the OC niche (Figure 2, I and J).
Adamts7 and Ctgf Genes Are Coexpressed in OC
Compartments
Transgenic mice expressing GFP under the control of Ctgf
promoter (CTGFp-GFP) are useful tools to track Ctgf-
expressing cells in vivo.21 To monitor the expression pattern
between Ctgf and Adamts7 gene, we mated CTGFp-GFP
transgenic mice to Adamts7 KOs and generated Adamts7/,
CTGFp-GFPþ/, and backcrossed with the Adamts7 KO
strain for more than six generations. Consistent with our
recent report describing induction of Ctgf promoter activity in
reactive ducts after DDC treatment in mice,21 dual staining for
GFP and EpCAM detected Ctgf expression in cholangiocytes
and OCs from CTGFp-GFP transgenic mice that contained
wild-type or Adamts7/ alleles after 12-day DDC treatment
(Figure 3A). Quantitative analysis of GFPþ areas showed that
Adamts7/, CTGFp-GFPþ/mice hadmoreCtgf expression
than Adamts7þ/þ, CTGFp-GFPþ/ controls [9.32% 0.93%
(KO) versus 7.44%  0.39% (control); P < 0.05, Student’s
t-test] (Figure 3B). Furthermore, IHC for b-galactosidase andThe American Journal of Pathology - ajp.amjpathol.orgGFP as indicators for Adamts7 and Ctgf genes, respectively,
showed their expression in distinct, but closely associated, cell
populations within the progenitor cell compartment of DDC-
treated Adamts7/, CTGFp-GFPþ/ mice (Figure 3C).
Adamts7 Deﬁciency Causes Up-Regulation of the
Hepatic Ctgf Gene at Both mRNA and Protein Levels in
KO Mice
To clarify the functional relationship between Adamts7 and
Ctgf genes, we compared their transcriptional levels between
wild-type andKOmice duringDDC-induced liver injury. IHC
for b-galactosidase and GFP showed remarkable induction of
Adamts7 and Ctgf genes in livers of Adamts7/, CTGFp-
GFPþ/mice thatwere fed a 0.1%DDC-containing diet for 12
days as compared to these mice on a regular diet (Figure 3C).
Semiquantitative RT-PCR analysis detected absence of full-
length Adamts7 transcript using primers ﬂanking exons 4
and 7 of this gene from all tested Adamts7/ individuals,
whereas Adamts7þ/þ animals that were fed a DDC diet for 12
days produced signiﬁcant induction of the full-lengthAdamts7
(Figure 3D). Despite similar levels between the two types of
miceon regular chow,CTGFmRNAandproteinwere induced
to a greater extent in DDC-treated Adamts7/mice than wild-
type controls (Figure 3, D and E). Densitometric analysis of
band intensity indicated that Adamts7/ livers had a 33% in-
crease of relative amount of CTGF protein than Adamts7þ/þ
controls at 12 days of DDC treatment [0.9  0.11 (control)
versus 1.2 0.08 (KO); P< 0.05, Student’s t-test] (Figure 3, E
and F). IHC analysis revealed more accumulation of CTGF
protein in OC compartments adjacent to periportal parenchyma
ofDDC-damagedAdamts7/ livers thanAdamts7þ/þ controls,
although there was no signiﬁcant difference of CTGF staining
on liver sections of both types of animals on regular chow
(Figure 3G). These observations suggest that Adamts7 deletion
is associated with up-regulation of theCtgf gene at both mRNA
and protein levels during OC activation induced by a DDC diet.
Adamts7 Deﬁciency Enhances OC Response in KO Mice
Because CTGF plays an important role in OC activation,20,21
its substantial up-regulation led us to hypothesize that dele-
tion of the Adamts7 gene would elicit an increased OC
response. Dual staining for A6 and Ki-67 revealed that
Adamts7/ mice had an approximately 34% increase in OC
proliferation within OC compartments when compared to
Adamts7þ/þ controls after feeding a DDC diet for 12 days
[36.1%  1.4% (control) versus 48.2%  2.3% (KO);
P < 0.05, Student’s t-test] (Figure 4, A and B). In contrast,
DDC treatment caused a 40% decrease of Ki-67þ hepatocytes
in Adamts7/mice as compared to controls [2.1% 0.18%
(control) versus 1.5%  0.12% (KO); P < 0.05, Student’s
t-test]. Fibronectin and laminin were two OC-associated
matrix proteins.21,35 IHC analysis detected denser networks
of ﬁbronectin and concentrated laminin around portal tract
regions in the DDC-damaged Adamts7/ livers than the1557
Figure 2 Adamts7 is induced during oval cell
(OC) activation, particularly in hepatocytes and
myoﬁbroblasts within the OC compartment of 3,5-
diethoxycarbonyl-1,4-dihydrocollidine (DDC)efed
Adamts7 knockout mice. A: Induction of Adamts7 is
detected in livers of 2-acetylaminoﬂuorene (2-AAF)e
implanted, partially hepatectomized (PHx) rats by
Northernblot analysis and in livers of DDC-fedmice by
semiquantitative RT-PCR analysis using primers
ﬂanking exons 4 and 7. B: Schematic representation
of Adamts7þ and Adamts7 alleles. Knockout mice
were generated using an Adamts7 target allele con-
taining two FLP recombinase target sequences (FRT),
an engrailed two-splice acceptor (En2SA), an internal
ribosome entry site (IRES), b-galactosidase (LacZ),
two polyadenylation sequences (pA), three cre
recombinase target sequences (LoxP), human b-actin
promoter (hbactP), and a neomycin resistance gene
(Neo) inserted into the ﬁfth intron of the Adamts7
locus. A 23-kb EcoRI (EI ) fragmentwas present in the
wild-type allele, whereas the gene trap construct
generated amutant7-kb EI fragment in theAdamts7
allele. C: Adamts7/ animals were identiﬁed using a
hybridization probe ﬂanking exon 6 in Southern blot
analyses of EI-digested genomic DNAs. D: Loss of the
full-length Adamts7 mRNA was conﬁrmed by RT-PCR
analysis in Adamts7/ tissues using primers ﬂank-
ing exons 4 and 7. EeJ:X-Gal staining in combination
with immunohistochemistry for A6 (E and F), HNF4a
(G), desmin (H), CD45 (I), or F4/80 (J)was performed
to track Adamts7-expressing cells (arrows) in livers
of Adamts7/ mice after 28-day DDC treatment.
Dark brown precipitates are artifacts from porphyrin
pigments due to DDC feeding. Scale barZ 250 mm.
Gapdh, glyceraldehyde-3-phosphate dehydroge-
nase; M, 100 bp DNA marker.
Pi et alwild-type controls (Figure 4C). Trop2 and EpCAM are OC
markers.34 Semiquantitative RT-PCR analysis detected up-
regulation of Trop2, EpCAM, and the biliary marker CK19
in livers of Adamts7/ mice in comparison to wild-type
controls after 12 days of DDC feeding (Figure 4D). These
results indicate that Adamts7 deﬁciency causes an enhanced
OC response during DDC-induced liver injury.1558Adamts7 Deﬁciency Increases Biliary Fibrogenesis in
KO Mice
To understand the role of Adamts7 during liver ﬁbrogenesis,
we compared the expression of ﬁbrosis-related genes between
Adamts7þ/þ and Adamts7/ mice after DDC treatment.
Semiquantitative RT-PCR analysis showed that a-SMA andajp.amjpathol.org - The American Journal of Pathology
Figure 3 Ctgf and Adamts7 genes are coexpressed in oval cell (OC) compartments of 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)edamaged mouse
livers, where loss of the Adamts7 gene is associated with up-regulation of connective tissue growth factor (CTGF) at mRNA and protein levels. A: Dual staining for
green ﬂuorescent protein (GFP) and epithelial cell adhesion molecule (EpCAM) indicates ductular expression of Ctgf gene in 12-day DDC-treated Adamts7þ/þ and
Adamts7/mice carrying the CTGFp-GFP transgene. B:More cells expressing Ctgf promoter activity are seen in 12-day DDC-damaged livers of Adamts7/, CTGFp-
GFPmice than in Adamts7þ/þ, CTGFp-GFP animals on the basis of quantitative analysis of GFPþ areas using ImageJ 1.46r software. C: Immunohistochemistry (IHC)
for b-galactosidase (blue signal) and GFP (red signal) on 12-day DDC-treated or regular dietefed Adamts7/, CTGFp-GFP mice. Ctgf-expressing OCs and biliary
epithelial cells are closely associated with Adamts7-expressing cells in OC compartments of DDC-damaged livers. In contrast, few of Ctgf- and Adamts7-expressing
cells were detected in regular dietefed Adamts7/, CTGFp-GFPmice. D and E: CTGF mRNA and protein were measured by semiquantitative RT-PCR (D) and Western
blot analyses (E) in animals that were fed regular diet or treated with the DDC diet for 12 days. Three different individual animals per group were analyzed and
shown. F: Quantiﬁcation analysis shows that DDC treatment induces a higher level of CTGF protein in Adamts7/ than Adamts7þ/þ mice, whereas no signiﬁcant
difference of CTGF protein is found in the two types of mice that were fed regular diet. Level of CTGF protein was calculated on the basis of densitometric analysis
of relative band intensity between CTGF and b-actin in E. G: IHC for CTGF (red signal) on liver sections of 12-day DDC-treated or regular dietefed Adamts7/ and
Adamts7þ/þ mice. Data are means  SEM (B) or means  SD (F). n Z 3 per group (B). *P < 0.05 (F). Scale bars: 150 mm (A and C); 100 mm (G). Original
magniﬁcation, 200 (B). KO, knockout; WT, wild type.
ADAMTS7 in Liver Repairprocollagen a1(I) mRNAs were signiﬁcantly up-regulated in
Adamts7/ livers in comparison to Adamts7þ/þ livers at day
12 after DDC treatment (Figure 4D). IHC and quantitative
analysis showed that these DDC-treated Adamts7/ liversThe American Journal of Pathology - ajp.amjpathol.orghad a 27% increase in a-SMAþ areas [3.71%  0.13%
(control) versus 4.7%  0.21% (KO); P < 0.05, Student’s t-
test] and a 23% increase in Sirius redestained collagen ﬁbrils
[7.36%  0.22% (control) versus 9.08%  0.81% (KO);1559
Figure 4 Adamts7 inactivation is associated
with increased oval cell (OC) activation and biliary
ﬁbrosis in response to 3,5-diethoxycarbonyl-1,4-
dihydrocollidine (DDC). A: Representative images
show A6 and Ki-67 dual staining on liver sections of
Adamts7þ/þ andAdamts7/mice that were fed the
DDC diet for 12 days. Arrowheads point to Ki-67þ
hepatocytes; arrows, Ki-67þ biliary epithelial cells.
B: Quantitative analyses determined numbers of Ki-
67þ biliary epithelial cells and Ki-67þ hepatocytes.
OC proliferation was indicated by a ratio between
the number of Ki-67þA6þ cells/total number of A6þ
cells per ﬁeld. Hepatocyte proliferation denotes the
number of Ki-67þ hepatocytes per ﬁeld. Five ﬁelds
were assessed per liver section from three animals
per group. C: Representative images show immu-
noﬂuorescence staining for ﬁbronectin and laminin
on Adamts7þ/þ and Adamts7/mice that were fed
the DDC diet for 12 days.D: Semiquantitative RT-PCR
analyses were performed to determine the mRNA
levels of OC markers Trop2, epithelial cell adhesion
molecule (EpCAM), and CK19, and ﬁbrosis markers
a-smoothmuscle actin (SMA) and collagen type I(a)
from Adamts7þ/þ and Adamts7/ animals that
were fed the DDC diet for 12 days. E and F: Repre-
sentative images show immunohistochemistry for
a-SMA (E) and Sirius red staining for collagen (F) on
liver sections from 12-day DDC-treatedmice. Graphs
show quantiﬁcation of a-SMAþ (E) or Sirius rede
stained areas (F) on the basis of image analysis of at
least ﬁve random ﬁelds per slide. G: Hepatic hy-
droxyprolinecontentwasmeasured fromAdamts7þ/þ
and Adamts7/ mice that were fed the DDC diet for
12 days. Three animals per group were scored. Data
aremeans SEM(B andG).nZ3miceper group(G).
*P< 0.05. Scale bars: 50mm(A); 250mm(C); 150mm
(E and F). Original magniﬁcation,200 (B, E, and F).
KO, knockout; WT, wild type.
Pi et alP < 0.05, Student’s t-test] (Figure 4, E and F). Biochemical
collagen assessment by hydroxyproline assay detected an
approximately 19% increase in hepatic collagen [1.38 0.09
(control) versus 1.64  0.12 (KO) mg/g body weight;
P< 0.05, Student’s t-test] in the Adamts7/ livers compared
to the controls at day 12 of DDC treatment (Figure 4G). These
results indicated that Adamts7 deﬁciency promotes the
ﬁbrogenic response during DDC-induced liver injury.Discussion
ECM is one of the most important regulators in HPC/OC
niches, providing physical scaffold and structural support for
hepatic cells. In addition, it serves as a reservoir for many
extracellular signaling molecules, such as growth factors, and
dynamically regulates cell adhesion, migration, differentia-
tion, proliferation, and survival. Proteolysis and remodeling
of ECM is a key feature of tissue regeneration and angio-
genesis. Extracellular proteases can degrade ECM compo-
nents, liberate growth factors, and remodel provisional
matrix that primes cell motility and mobility at appropriate1560times. However, loss of proteolysis can cause dysregulation
of ECM production and the development of liver pathol-
ogy.36 For example, Kallis et al37 reported that reduced
collagen turnover in collagen Ia1(r/r) mice that bear mutation
and resistance to matrix metalloproteinase degradation in
collagen I is associated with decreased OC activation, failure
to deposit laminin, and exaggerated ﬁbrosis after liver injury
induced by chronic carbon tetrachloride intoxication and the
choline-deﬁcient ethionine-supplemented diet. Loss of ma-
trix metalloproteinase-2, a type IV collagenase secreted by
activated hepatic stellate cells, exacerbates cholestatic liver
ﬁbrosis and ampliﬁes carbon tetrachlorideeinduced liver
ﬁbrosis by up-regulating collagen I expression in mice.38,39
Consistent with these ﬁndings, this study demonstrated the
regulation of OC activation and biliary ﬁbrosis by
ADAMTS7, a new protease for CTGF. The Adamts7 gene
was highly expressed in myoﬁbroblast cells and hepatocytes
within HPC niches, and its deﬁciency appeared to slow down
CTGF turnover and enhance HPC/OC activation and biliary
ﬁbrosis during DDC-induced liver injury.
The matricellular protein CTGF exhibits a four modular
protein structure with a protease-sensitive hinge regionajp.amjpathol.org - The American Journal of Pathology
ADAMTS7 in Liver Repairlinking domains II and III.23 Small bioactive isoforms of 10
to 20 kDa, corresponding to different CTGF domains, have
been found in tissue culture and body ﬂuids.23,24,40 Elevated
levels of N-terminal CTGF fragments are reported in several
ﬁbroproliferative disorders.41,42 The N-terminal half of
CTGF, together with insulin growth factor-2, promotes
differentiation and collagen synthesis of myoﬁbroblasts,
whereas the C-terminal region mediates ﬁbroblast prolifera-
tion in concert with epidermal growth factor.43 The existence
of small CTGF fragments implicates proteolysis as an
important mechanism in regulating the biological activity
and availability of CTGF. Indeed, matrix metalloproteinases,
including 1, 2, 3, 7, and 13, have been found to cleave CTGF
and release vascular endothelial growth factor-A from
anti-angiogenic complexes.44,45 Our study showed that
ADAMTS7 was able to bind to and process CTGF in vitro.
Although the exact cleavage site(s) on CTGF remain to be
determined in the future, genetic evidence using Adamts7/
mice implicated that ADAMTS7 facilitated CTGF turnover
because its loss caused an accumulation of CTGF protein
within OC compartments during DDC-induced liver injury.
ADAMTS7 and ADAMTS12 are classiﬁed into a pro-
teoglycan subgroup on the basis of possession of a common
mucin domain that attaches to glycosaminoglycan chon-
droitin sulfate.30 We found that the mucin domain, in com-
bination with TSRs 5 to 8 and the PLAC domain, was
required for CTGF interaction, suggesting that the C-terminal
ADAMTS7 is required for recognition of CTGF substrate in
the extracellular environment. In contrast, three other known
substrates, cartilage oligomeric matrix protein, progranulin,
and a2-macroglobulin, do not require the mucin domain,
TSRs 5 to 8, and the PLAC domain for their binding to
ADAMTS7.46,47 Cartilage oligomeric matrix protein and
progranulin protein interact with four C-terminal TSRs of
ADAMTS7, and a2-macroglobulin only needs the metal-
loproteinase domain of ADAMTS7 for its cleavage.30,33,46,47
These observations suggest that ADAMTS7 binds to sub-
strates through multiple sites, likely depending on tertiary
structures or shapes of this enzyme and each substrate.
ADAMTSs are secreted admalysin-thrombospondins that
play an important role in cell phenotype regulation via their
activities during ECM remodeling: interacting with sub-
strates, including adhesion ligands, growth factors, and ECM
proteins.28,29 ADAMTS1 is up-regulated in hepatic stellate
cells and controls transforming growth factor-b activation
and liver ﬁbrosis during chronic liver injury.48 ADAMTS2
processes collagen type I, II, III, and V precursors into mature
molecules by excising aminopropeptide. Its inactivation re-
duces the extent and stability of carbon tetrachloridee
induced hepatic ﬁbrosis in mice.49 ADAMTS 1, 4, and 5 may
be involved in hepatocellular carcinoma.50 The liver func-
tions of other ADAMTS members remain largely unknown.
This study identiﬁed ADAMTS7 as a new extracellular
protease in the regulation of CTGF protein availability during
ductular reaction and biliary ﬁbrogenesis. Semiquantitative
RT-PCR analyses detected high levels of Adamts1 andThe American Journal of Pathology - ajp.amjpathol.orgAdamts2 mRNAs that were independent of the Adamts7
genotype because Adamts7 KOs and wild-type controls
shared similar expression patterns of Adamts1 and Adamts2
in both normal and DDC-damaged conditions (Supplemental
Figure S1). Therefore, ADAMTS1 and/or ADAMTS2 may
have overlapping functions with ADAMTS7 and partially
compensate for loss of ADAMTS7 during OC activation and
liver ﬁbrosis. Nevertheless, this study showed signiﬁcant
accumulation of CTGF in the absence of ADAMTS7.
Proliferating cholangiocytes and activated OCs highly
expressed Ctgf, whereas the Adamts7 gene was up-regulated
in myoﬁbroblasts and hepatocytes adjacent to these reactive
ducts. Given that CTGF has known functions in the adhesion,
migration, and differentiation of OCs and myoﬁbroblasts, it is
conceivable that rapid turnover by ADAMTS7 processing
limits CTGF availability for OC proliferation, myoﬁbroblast
activation, and excessive ECM production in OC compart-
ments, thereby reducing/preventing abnormal liver repair. It is
intriguing to consider whether overexpression of ADAMTS7
inhibits HPC/OC activation and liver ﬁbrosis in future studies.
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